Preview

Safety and Risk of Pharmacotherapy

Advanced search
Fullscreen

For citations:


Makarova T.A., Zagorodnikova K.A., Makarov I.A., Dobrynina N.V., Sventitskaya E.E., Lobacheva Yu.N. Fatal Rhabdomyolysis after Rosuvastatin Dose Modification in Acute Coronary Syndrome: A Case Report. Safety and Risk of Pharmacotherapy. 2025;13(3):333-343. (In Russ.) https://doi.org/10.30895/2312-7821-2025-13-3-333-343

Views PDF (Rus): 13


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)